ACE2 and COVID-19: Immunoperoxidase studies showed focal expression of the main COVID-19 receptor angiotensin-converting enzyme-2 (ACE2) on placental syncytiotrophoblast [Hikmet et al., 2020], immediately at the feto-maternal interface.